Persistent symptoms at the end of 3 months after Acute COVID-19 infection among adult patients admitted to a tertiary care centre: A descriptive longitudinal study
Abstract
Background: COVID-19 has affected all corners of the world. Multiple symptoms reported during the hospital stay may persist after the patient discharged from the hospital. Objectives: 1) To study the persistence of symptoms at the end of 3 months after acute COVID-19 infection among adult patients admitted to a tertiary care centre. 2) To review their symptoms during the acute COVID-19 infection. 3) To study the association between various factors and the persistence of symptoms of acute COVID-19 infection.
Material & Method: This was a descriptive longitudinal study conducted in November 2021. The sample included 200 laboratory-confirmed COVID-19 cases discharged from the tertiary care hospital of Pune City after obtaining written informed consent.Epidemiological information was obtained by telephonic interview with predesigned and pretested proforma covering socio-demographic data, related factors and information about the onset and duration of symptoms after the patient was discharged from the hospital.
Results: The study involved 200 recovered COVID-19 patients (115 males, 85 females) with a mean age of 46.42 ± 16.22 years. Notably, 90% of males had some form of addiction, compared to 10% of females, revealing a significant gender disparity (p value <0.0001). Fatigue (75.50%), cough (73%), and fever > 38.0 OC(69.50%) were prevalent persistent symptoms. A statistically significant association of persistence of symptoms was found with age and COVID-19 vaccination status.
Conclusion: Our study provides crucial insights into long-term COVID-19 symptoms, advocating targeted interventions considering demographic factors. This comprehensive approach guides effective management of persistent symptoms post-COVID-19.
Salunke P H, Kendre V V, Parande M A, Patekar A
U, Tambe M P, Jadhav Y U, Jagdale G R, Hatnapure
M, Borle P, Shinde P V, Mule N D, Baviskar R N,
Pardeshi S S. Persistent Symptoms at the End of
3 Months after Acute COVID-19 Infection among
Adult Patients Admitted to a Tertiary Care Centre:
A Descriptive Longitudinal Study. J Commun Dis.
2024;56(3):119-126.
DOI: https://doi.org/10.24321/0019.5138.202456
References
Worldometer [Internet]. India: Coronavirus cases; [cited 2024 Apr 11]. Available from: https://www.
worldometers.info/coronavirus/country/india/
Johns Hopkins University and Medicine [Internet]. Ongoing Johns Hopkins COVID-19 resources; [cited
Jun 1]. Available from: https://coronavirus.jhu.edu/
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B, Li LJ, Zeng G, Yuen KY,
Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng
P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment
Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med.
;382(18):1708-20. [PubMed] [Google Scholar]
Carfi A, Bernabei R, Landi F; Gemelli Against COVID-19
Post-Acute Care Study Group. Persistent symptoms in
patients after acute COVID-19. JAMA. 2020;324(6):603-
[PubMed] [Google Scholar]
Goertz YM, Van Herck M, Delbressine JM, Vaes AW, MEYS R, Machado FV, Houben-Wilke S, Burtin
C, Posthuma R, Franssen FM, Loon NV, Hajian B, Spies Y, Vijlbrief H, Hul AJ, Janssen DJ, Spruit MA.
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open
Res. 2020;6(4):00542-2020. [PubMed] [Google Scholar]
Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A Review of Persistent Post-COVID
Syndrome (PPSC). Clin Rev Allergy Immunol. 2023 Feb;64(1):66-74. [PubMed] [Google Scholar]
National Institute for Health and Care Excellence [Internet]. COVID-19 rapid guideline: managing the
long-term effects of COVID-19; 2020 [cited 2024 Apr 10]. Available from: https://www.nice.org.uk/
guidance/ng188
Ayoudkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. PostCOVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ.
;372:n693. [PubMed] [Google Scholar]
MyGov [Internet]. https://www.mygov.in/covid-19accessed on 1 June 2021
Pune Municipal Corporation [Internet]. Available from: https://www.pmc.gov.in accessed on 1 June 2021
Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline
HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID,
Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR; IVY Network Investigators.
Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19
in a multistate healthcare systems network- United States, March-June 2020. MMWR Morb Mortal Wkly
Rep. 2020;69(30):993-8. [PubMed] [Google Scholar]
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas
LS, Molteni E, Modat M, Cardoso MJ, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi
AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FM, Franks PW, Chan AT, Wolf
J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626-
[PubMed] [Google Scholar]
National Institute for Health and Care Excellence [Internet]. [cited 2023 Dec 9]. Available from:
https://www.nice.org.uk/guidence/cg53/chapter/1-Guidance#diagnosis
Hempel S, Chambers D, Bagnall AM, Forbes C. Risk factors for chronic fatigue syndrome/myalgic
encephalomyelitis: a systematic scoping review of multiple predictor studies. Psychol Med.
;38(7):915. [PubMed] [Google Scholar]
Chen FJ, Li FR, Zheng JZ, Zhou R, Liu HM, Wu KY, Zhang B, Dong H, Lu JY, Lei CL, Wu XB. Factors associated
with duration of hospital stay and complications in patients with COVID-19. J Public Health Emerg.
;5:6. [Google Scholar]
Copyright (c) 2024 Journal of Communicable Diseases (E-ISSN: 2581-351X & P-ISSN: 0019-5138)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.